Akari Therapeutics Plc - AKTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Interim CFO | A | A | 1,728.0 | 7.52 | 12,994.56 | 23,309.0 | View | |
| Aug 05, 2026 | Interim CFO | A | A | 1,130.0 | 11.5 | 12,995.0 | 21,581.0 | View | |
| Jul 17, 2026 | — | M | A | 5,799.0 | 16.16 | 93,711.84 | 0.0 | View | |
| Jul 17, 2026 | — | M | A | 15,466.0 | 16.16 | 249,930.56 | 0.0 | View | |
| Jul 17, 2026 | — | M | A | 1,209.0 | 32.0 | 38,688.0 | 0.0 | View | |
| Jul 17, 2026 | — | M | A | 5,799.0 | 0.0004 | 2.32 | 98,241.0 | View | |
| Jul 17, 2026 | — | M | A | 15,466.0 | 0.0004 | 6.19 | 92,442.0 | View | |
| Jul 17, 2026 | — | M | A | 1,209.0 | 8.0 | 9,672.0 | 76,976.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,000.0 | 13.0 | 13,000.0 | 20,452.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 7,353.0 | 3.74 | 27,500.22 | 19,452.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 3,725.0 | 3.49 | 13,000.25 | 12,099.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 2,539.0 | 5.12 | 12,999.68 | 8,374.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,570.0 | 8.28 | 12,999.6 | 5,835.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,395.0 | 9.32 | 13,001.4 | 4,265.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,248.0 | 10.02 | 12,504.96 | 2,870.0 | View | |
| Jun 25, 2026 | CEO | A | A | 15,563.0 | 0.0 | 0.0 | 15,563.0 | View | |
| Jun 25, 2026 | CEO | A | A | 5,500.0 | 0.0 | 0.0 | 5,500.0 | View |